Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$101.21 - $166.61 $1.79 Million - $2.94 Million
-17,660 Reduced 69.87%
7,614 $904,000
Q1 2024

Apr 05, 2024

BUY
$85.37 - $115.44 $2.16 Million - $2.92 Million
25,274 New
25,274 $2.69 Million
Q2 2023

Aug 03, 2023

SELL
$118.5 - $160.53 $2,962 - $4,013
-25 Reduced 1.44%
1,708 $207,000
Q1 2023

May 04, 2023

SELL
$135.66 - $197.02 $4.47 Million - $6.49 Million
-32,927 Reduced 95.0%
1,733 $266,000
Q4 2022

Feb 06, 2023

SELL
$118.38 - $210.04 $5.02 Million - $8.91 Million
-42,408 Reduced 55.03%
34,660 $6.23 Million
Q3 2022

Nov 02, 2022

SELL
$118.07 - $194.18 $8.61 Million - $14.2 Million
-72,955 Reduced 48.63%
77,068 $9.11 Million
Q2 2022

Aug 05, 2022

SELL
$117.13 - $176.59 $24.3 Million - $36.6 Million
-207,467 Reduced 58.03%
150,023 $21.4 Million
Q1 2022

May 06, 2022

BUY
$126.46 - $235.05 $30.2 Million - $56.2 Million
239,093 Added 201.94%
357,490 $61.6 Million
Q4 2021

Feb 03, 2022

SELL
$225.82 - $368.51 $6.18 Million - $10.1 Million
-27,375 Reduced 18.78%
118,397 $30.1 Million
Q3 2021

Nov 08, 2021

SELL
$221.9 - $484.47 $21.1 Million - $46 Million
-95,047 Reduced 39.47%
145,772 $56.1 Million
Q2 2021

Aug 05, 2021

BUY
$129.91 - $234.98 $2.11 Million - $3.81 Million
16,228 Added 7.23%
240,819 $56.6 Million
Q1 2021

May 05, 2021

SELL
$109.18 - $185.98 $7.27 Million - $12.4 Million
-66,612 Reduced 22.87%
224,591 $29.4 Million
Q4 2020

Feb 04, 2021

BUY
$65.74 - $169.86 $16.3 Million - $42.2 Million
248,239 Added 577.78%
291,203 $30.4 Million
Q3 2020

Nov 02, 2020

SELL
$54.34 - $94.85 $435,752 - $760,602
-8,019 Reduced 15.73%
42,964 $3.04 Million
Q2 2020

Aug 05, 2020

BUY
$29.67 - $80.0 $1.51 Million - $4.08 Million
50,983 New
50,983 $3.27 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.